CVS Health Corporation (NYSE:CVS) is included among the 20 Best Performing Dividend Stocks in 2025. JPMorgan Names CVS a Top Pick as Turnaround Gains Traction The stock dropped 43% in 2024, then swung the other way with an 80.5% gain this year. Even after that run, Wall Street still sees room to move. The average analyst price target points to another 19% upside.Earlier in December, JPMorgan named CVS Health Corporation (NYSE:CVS) as a top pick in health care services. “We remain positive on CVS post-Inv ...

公司人事与股权激励 - Evolent Health Inc 宣布其董事会薪酬委员会批准向新任首席财务官Mario Ramos先生授予一笔一次性基于时间的限制性股票单位奖励 该奖励涉及587,500股Evolent A类普通股 面值为每股0.01美元[1] - 该诱导奖励的授予日期价值为2,350,000美元 其归属计划为授予日第一周年后归属34% 第二周年后归属33% 第三周年后归属33% 前提是Ramos先生在该奖励的每个适用归属日期前持续在职[2] - 此项奖励是根据纽约证券交易所上市规则303A.08授予的 作为吸引Ramos先生加入公司的重要物质诱导条件 因其此前并非公司员工或离职后重新雇用的前员工[1] 公司业务概况 - Evolent Health Inc 专注于通过成熟的解决方案改善患有复杂疾病人群的健康结果 使医疗保健更简单、更可负担[1][3] - 公司为全国范围内的领先支付方和提供商提供服务 并持续被认可为全国医疗保健领域的顶级工作场所之一[3]

Jan. 2 marked the first trading session of 2026 for the U.S. stock market. And Bitcoin-treasury stock Kindly MD (NASDAQ: NAKA) is trading higher despite ongoing regulatory scrutiny. The rally follows a challenging few weeks for the healthcare-turned-crypto firm, which recently received a delisting notice from Nasdaq. Related: 'Alarming' growth of bitcoin treasuries prompts all-time high price prediction What is Kindly MD? Kindly MD, Inc. is a healthcare and healthcare data company that provides direct ...

With a 58% gain, CVS Health had its best year since 1982—and it wasn't the only strong performer. ...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Jan. 02, 2026 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing provider of home-based and community-based care services in North America, is pleased to announce the promotion of Melissa Anderson from her role as Vice President, Operations (U.S.) to Senior Vice President (U.S.), effective January 1, 2026. Ms. Anderson joined Nova Leap in 2018 and has p ...

美国流感季疫情加剧，新毒株出现或导致疫苗防护效果下降，新冠病例则持续处于低位。 ▸ 核心提要 美国流感确诊病例连日走高，疾控部门担忧当前流感疫苗对流行的新毒株防护效果不足。公共卫生专家 表示，本轮流感季虽已进入高发期，但尚未达峰值，病例激增符合往年流感季的流行规律，疫苗仍能有 效降低重症风险。新冠疫情则持续缓和，污水监测数据显示病毒传播水平远低于夏季峰值。 文 / 戴维・奥瓦列 美国流感确诊病例呈上升趋势，主导疫情的是一种新型流感毒株，公共卫生部门担忧现有疫苗无法对其 形成有效防护。 卫生官员与研究人员指出，尽管本轮流感季尚未迎来峰值，此次病例激增并非历史罕见情况，同时强调 疫苗大概率仍能抵御该毒株引发的重症风险。 美国疾控中心数据显示，流感相关的住院、急诊、门诊就诊人次及死亡病例均大幅上升，不过美国流感 疫情峰值预计要到明年初才会到来，大概率在 2 月。 布朗大学公共卫生学院大流行病研究中心主任、流行病学家詹妮弗・努佐表示："本轮流感病例增长虽 略显迅猛，但实属正常。流感季的疫情传播向来来势汹汹。" 冬季的环境条件极易助长流感、新冠、呼吸道合胞病毒等空气传播类病毒的扩散，民众长期聚集在室 内、节假日出行增多 ...

诉讼概述 - 罗森律师事务所代表在2025年2月26日至2025年8月4日期间购买agilon health, inc. (NYSE: AGL) 证券的购买者提起集体诉讼 [1] - 诉讼指控被告在集体诉讼期间做出了虚假和/或误导性陈述，和/或未能披露相关信息 [5] 指控内容 - 被告鲁莽地发布了2025年业绩指引，而他们知道或本应知道在已知的重大行业阻力下该指引无法实现 [5] - 被告在材料层面夸大了agilon为降低风险所采取的“战略行动”会带来的即时积极财务影响 [5] - 因此，被告关于agilon业务、运营和前景的陈述在所有时间点都存在重大虚假和/或误导性 [5] - 当真实情况进入市场时，投资者遭受了损失 [5] 律师事务所信息 - 罗森律师事务所是一家全球投资者权益律师事务所，专注于证券集体诉讼和股东衍生诉讼 [4] - 该所曾达成针对中国公司的史上最大证券集体诉讼和解 [4] - 根据ISS证券集体诉讼服务的数据，该所2017年在证券集体诉讼和解数量上排名第一 [4] - 自2013年以来，该所每年排名前四，已为投资者追回数亿美元 [4] - 仅在2019年，该所就为投资者确保了超过4.38亿美元 [4]

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities." Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects Share For more information, sub ...

On October 7, Owens & Minor, Inc. announced a definitive agreement to sell its P&HS segment along with the Owens & Minor brand. The Company completed the sale to Platinum Equity for $375 million in cash, subject to certain customary adjustments for cash, indebtedness, net working capital, and transaction expenses, and a 5% retained equity stake while also preserving tax attributes in excess of $150 million. Safe Harbor RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (the "Company†) announc ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period†). The lawsuit seeks to recover damages for agilon investors under the federal securities laws. To join the agilon class action, go to https://rosenlegal.com/submit-form/?case_id=46039 or call Phillip Kim, Esq. t. ...